Clinical Trials Directory

Trials / Completed

CompletedNCT02089074

Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack

Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack: Adherence and Cardiovascular Events in the First Three Months

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
265 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Use of drugs is an important factor in secondary prophylaxis after transient ischemic attack (TIA), but studies show that adherence to the prescribed drugs is often poor. This randomised controlled trial aims to investigate whether a systematic follow up of drug treatment using medication reconciliation, medication reviews and patient counselling by clinical pharmacists, improves adherence and/or decreases cardiovascular events the first three months and the first year after TIA. Patient satisfaction will also be compared between the two groups.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDrug use counselling

Timeline

Start date
2012-11-01
Primary completion
2015-09-01
Completion
2016-06-01
First posted
2014-03-17
Last updated
2017-03-30

Locations

6 sites across 1 country: Norway

Source: ClinicalTrials.gov record NCT02089074. Inclusion in this directory is not an endorsement.

Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack (NCT02089074) · Clinical Trials Directory